CLINICAL_TRIALS
trial_result
· 2012-11-01
Clinical Trial Update: S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 SWOG trial S0213 evaluating chemotherapy plus rituximab in mantle cell lymphoma has completed; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-11-01